150 mg VISMO (Erivedge 150 mg)
Generic Name: vismodegib
Pill imprint 150 mg VISMO has been identified as Erivedge 150 mg.
Erivedge is used in the treatment of basal cell carcinoma and belongs to the drug class hedgehog pathway inhibitors. There is positive evidence of human fetal risk during pregnancy. Erivedge 150 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about Erivedge (vismodegib)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.